Estudio descriptivo de las características del cáncer diferenciado de tiroides en Cataluña en el periodo 1998-2012. Registro CECaT

Zafon, Carles; Puig-Domingo, Manel; Biarnés, Josefina; Halperin, Irene; Bella, Maria Rosa; Castells, Ignasi; González, Cintia; Megía, Ana; Santos, Lola; García-Pascual, Luís; Reverter, Jordi Lluís; Pizarro, Eduarda; Mauricio , Dídac.
Endocrinol. nutr. (Ed. impr.) ; 62(6): 264-1269, jun.-jul. 2015. tab, ilus
Artículo en Español | IBECS (España) | ID: ibc-140169

Documentos relacionados

  1. Thirty years of active surveillance for low-risk thyroid cancer, lessons learned and future directions.
  2. Observational management of papillary microcarcinoma appearing in the remnant thyroid after hemithyroidectomy.
  3. Long-term predictive value of highly sensitive thyroglobulin measurement.
  4. Chronology of Thyroid Cancer.
  5. Clinicopathologic predictors of central lymph node metastases in clinical node-negative papillary thyroid microcarcinoma: a systematic review and meta-analysis.
  6. Changes in the diagnosis of thyroid tumours in the 5th edition of the WHO classification of endocrine neoplasms.
  7. Mouse Models to Examine Differentiated Thyroid Cancer Pathogenesis: Recent Updates.
  8. The Clinical Utility of Preoperative Thyroglobulin for Surgical Decision Making in Thyroid Disease.
  9. Clinical conditions related to positive thymic uptake on I-131 post-therapeutic scans in thyroid cancer patients.
  10. Incidental T1 stage medullary thyroid carcinoma: The effect of tumour diameter on prognosis and therapeutic implications.